From advancements in lipidomics to saturated fat-rich keto diets, interest in lipids is high right now. As you work with popular lipid supplements — specifically the phospholipid phosphatidylserine PS — it’s important to recognize the key role DHA plays in optimizing patient results.
Research published in Progress in Lipid Research clarifies how PS and DHA team up to enhance survival pathways, shape synaptic release, and even influence memory. The study also highlights how diet, alcohol, and targeted supplements are involved and impact brain signaling.
The Study: How PS Enables Key Survival Pathways
Scientists reveal that DHA-rich phospholipids are the preferred substrates for neuronal PS synthesis and adequate DHA increases membrane PS (especially the 18:0/22:6 species). This helps facilitate membrane recruitment and activation of survival and growth kinases (Akt, Raf), and it improves synaptic vesicle fusion. Clinically, maintaining or restoring DHA status (through diet or targeted supplementation) strengthens PS‑dependent signaling, enhances resilience to stressors, and may boost cognitive function and neural plasticity, making DHA assessment and optimization a practical priority in patients at developmental, aging, neurocognitive risk, mood changes, and more.
Key findings:
- PS is a major negatively charged phospholipid concentrated on the inner (cytoplasmic) leaflet of neuronal plasma membranes — 13–15% of cortical phospholipids (see Table 1, page 42, of the PDF).
- That negative charge and specific PS head‑group chemistry make PS a required docking surface for several signaling proteins. PS helps recruit and activate:
- Akt (protein kinase B): PS binding secures Akt at the membrane and permits activating phosphorylations (Fig. 8 on PDF). This is central for cell survival.
- Raf-1 and PKC: PS electrostatic interactions are needed for their membrane translocation and signaling.
- DHA (an omega‑3 fatty acid) promotes PS synthesis in neurons, selectively increasing DHA‑containing PS species (notably 18:0/22:6-PS; see Fig. 5 and Table 3 in PDF). That DHA-driven PS increase strengthens PS‑dependent activation of Akt/Raf and protects neurons from apoptosis in culture.
- Alcohol interferes: ethanol alcohol exposure reduces DHA‑promoted PS accumulation and downstream Akt phosphorylation, promoting neuronal apoptosis in models (section 8.1, pages 20–21, in PDF).
- PS influences synaptic function directly: it supports Ca2+-dependent synaptotagmin function and SNARE‑mediated vesicle fusion, thus aiding neurotransmitter release (section 7.3 in PDF).
- Clinical/translational signals: small randomized trials and animal studies report modest cognitive improvements with orally administered PS (often with omega‑3s), especially in older adults with memory complaints (section 9.1 in PDF). The mechanism in humans is not fully proven — oral PS may be hydrolyzed in the gut and benefits may stem from DHA delivery rather than intact PS incorporation.
Why this matters:
- Nutrition and brain signaling are linked: patients with low dietary omega‑3 intake or high n‑6:n‑3 ratios may have reduced brain DHA → reduced neuronal PS pools → weaker activation of survival/differentiation signaling (Akt/Raf) and potentially greater vulnerability to stressors.
- Practical take: counsel at‑risk patients (pregnant, older adults, heavy drinkers, those with poor diets) about omega‑3 intake (dietary sources or appropriate supplements per guidelines).
- Alcohol in pregnancy and development: experimental data show prenatal alcohol consumption lowers fetal DHA and PS, increasing neuronal apoptosis (page 20).
- Cognitive complaints in older adults: multiple modest trials report improved memory scores with PS-containing supplements (often combined with DHA/EPA). While results are mixed and mechanisms uncertain, PS/DHA supplementation might benefit some older patients with subjective memory complaints.
- Neuroprotection in stressful or degenerative states: because PS supports Akt survival signaling, interventions that maintain brain DHA/PS may theoretically add resilience — this is no replacement for disease‑specific therapy, but it is helpful as an adjunct consideration).
Research Gaps and Clinical Takeaways
- Most mechanistic data are cellular or animal work; human translation remains incomplete. The review notes that orally taken PS is likely partially hydrolyzed, so effects may be mediated by liberated DHA/EPA rather than intact PS incorporation.
- Clinical trials vary in PS source (soy, krill, bovine), dose and co‑ingredients; quality and generalizability differ. Evidence supports modest benefits for some older adults with memory complaints but is not definitive for dementia prevention or treatment.
- Safety: short-term trials report PS supplements are generally well tolerated at studied doses, but long-term safety data and interactions require consideration.
Study Takeaways
PS is a key membrane lipid that enables several core neuronal signaling pathways and synaptic functions; brain PS levels are tightly linked to DHA availability, and alcohol and poor dietary omega‑3 status can reduce PS and compromise neuron survival signals. For clinicians this means: optimize omega‑3 (DHA) intake in vulnerable patients (pregnancy, aging, heavy drinkers, those with cognitive complaints) as part of a pragmatic neuro‑protective strategy and recognize that PS supplements show modest, selective cognitive benefits in older adults.
→ Click here to download the FULL TEXT.
Reference
Kim HY, Huang BX, Spector AA. Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res. 2014 Oct;56:1-18. doi: 10.1016/j.plipres.2014.06.002. Epub 2014 Jun 30. PMID: 24992464; PMCID: PMC4258547.
